NIPH logo
Norwegian Institute of Public Health

Search result

102 hits
  1. Influenza vaccine

    Influenza vaccine

    Information and updated advice on the annual flu vaccine.
    [Kategori] Fagområde
  2. Seasonal influenza

    Seasonal influenza

    Advice, facts and statistics about influenza.
    [Kategori] Fagområde
  3. Avian influenza

    Avian influenza

    The NIPH gives advice to the Norwegian Food Safety Authority and other agencies on how to avoid transmission of avian influenza to humans. The NIPH closely follows national and international developments and has diagnostics available to detect avian influenza.
    [Kategori] Fagområde
  4. Influenza

    Influenza

    Last update

    Area
  5. NorFlu

    NorFlu

    The Norwegian Influenza Study (NorFlu) is exploring the potential effects of influenza A (H1N1) – swine flu – during pregnancy.
    Research study
  6. Influenza vaccine

    Influenza vaccine

    Last update

    Information note about vaccine against seasonal influenza. The publication contains information about risk groups and health benefits of influenza vaccination.
    Information note
  7. Influenza - Fact sheet about seasonal influenza

    Influenza - Fact sheet about seasonal influenza

    Last update

    Influenza causes fever and body aches as well as respiratory symptoms. Typically, five to ten per cent of the population becomes ill during a winter season. Influenza seasons vary in severity.
    Article
  8. Influenza vaccine for children

    Influenza vaccine for children

    Last update

    Most children and young adolescents can tolerate influenza (the ‘flu), but some can become seriously ill. Children and young people in risk groups often have a severe disease course and are therefore recommended to receive the influenza vaccine.
    Article
  9. Influenza vaccine for risk groups

    Influenza vaccine for risk groups

    Last update

    Anyone can become seriously ill from influenza, but certain risk groups are more susceptible to a severe disease course than others. In Norway, almost 1.6 million children and adults are in a risk group. The health benefits can be considerable if people in these risk groups are vaccinated.
    Article
  10. Narcolepsy after swine influenza pandemic

    Narcolepsy after swine influenza pandemic

    Last update

    A new Norwegian study confirms that the risk of narcolepsy was increased after vaccination with Pandemrix during the influenza pandemic in 2009/2010. It also suggests that the risk of narcolepsy increased after influenza, but these figures must be interpreted with caution.
    Research findings
  11. Influenza vaccine for pregnant women

    Influenza vaccine for pregnant women

    Last update

    Pregnant women are at increased risk of a severe influenza disease course. Therefore, the Norwegian Institute of Public Health recommends that pregnant women in the 2nd and 3rd trimesters should take the influenza vaccine. Pregnant women in the 1st trimester with other additional risk factors are also recommended to take the vaccine.
    Article
  12. Information material about influenza vaccine

    Information material about influenza vaccine

    Last update

    Films and information notes about the seasonal influenza vaccine.
    Article
  13. Vaccine recommendations for influenza season 2024-2025

    Vaccine recommendations for influenza season 2024-2025

    Last update

    Almost 1.6 million people in Norway belong to groups with an increased risk of complications from influenza. They are recommended to take the seasonal influenza vaccine.
    Article
  14. Influenza in pregnancy and cancer in children

    Influenza in pregnancy and cancer in children

    Last update

    The background for this project is our lack of knowledge about the causes of childhood cancer.
    Project
  15. Good habits to prevent influenza (poster)

    Good habits to prevent influenza (poster)

    Last update

    The poster ”Good habits to prevent influenza” focuses on cough- and hand hygiene to prevent infection with influenza. It can be ordered for use where information to the public is required in English. Format 30 x 57 cm.
    Poster
  16. Influenza Virological and Epidemiological season report 2022-2023

    Influenza Virological and Epidemiological season report 2022-2023

    Last update

    The 2022-23 season started early, crossing the outbreak threshold of 10 % positives in week 48 (sentinel)/week 49 (comprehensive) and had a sharp first peak in weeks 51-52/2022 with 46 % positives in the sentinel and 25 % positives in the comprehensive surveillance.
    Report
  17. Vaccines for adults

    Vaccines for adults

    The adult immunisation programme offers coronavirus vaccine and influenza vaccines to everyone aged 65 and older, as well as children and adults in risk groups. Additionally, people aged 65 are offered a vaccine against pneumococcal disease.
    [Kategori] Fagområde
  18. Influenza Virological and Epidemiological 2023-2024 season report

    Influenza Virological and Epidemiological 2023-2024 season report

    Last update

    Overall, the 2023-2024 influenza season was of low-to-moderate magnitude, had a protracted course, with influenza A(H1N1) dominating also this season, but cocirculating with A(H3N2) viruses and with much less influenza B/Victoria-lineage viruses.
    Report
  19. Brief guide to influenza and coronavirus vaccines

    Brief guide to influenza and coronavirus vaccines

    Last update

    Brief information from the Norwegian Institute of Public Health about vaccines against influenza and coronavirus in several languages. The information is intended for people who are among the priority groups for vaccination but who, for various reasons, want or need a simpler presentation than in the more comprehensive public text.
    Information note
  20. Influenza and coronavirus vaccines for pregnant women

    Influenza and coronavirus vaccines for pregnant women

    Last update

    Information about coronavirus and influenza vaccination during pregnancy.
    Information note
  21. Influenza epidemiological information prepared for WHO informal meeting on strain composition for inactivated influenza vaccines for use in season 2018-19 Geneva, Feb 2018

    Influenza epidemiological information prepared for WHO informal meeting on strain composition for inactivated influenza vaccines for use in season 2018-19 Geneva, Feb 2018

    Last update

    Report submitted by Norway to WHO's influenza vaccine meeting in Geneva, February 2018.
    Report
  22. Effect of oseltamivir (TamifluR) for the prevention and treatment of influenza during an influenza pandemic

    Effect of oseltamivir (TamifluR) for the prevention and treatment of influenza during an influenza pandemic

    Last update

    Health technology assessment
  23. Advice to prevent spread of avian influenza to humans

    Advice to prevent spread of avian influenza to humans

    Last update

    There is an outbreak of avian influenza (bird flu) among wild birds in Norway. In recent years, the avian influenza virus has also been detected among poultry flocks and in a small number of red foxes. Although the virus is rarely transmitted to humans, precautions should be taken.
    Article
  24. Influenza vaccination of elderly and people with chronic illness

    Influenza vaccination of elderly and people with chronic illness

    Last update

    This review presents the available documentation of the health effects of influenza vaccination to the elderly and people suffering from chronic illness.
    Systematic review
  25. Pregnant? Poster for vaccines against influenza and coronavirus

    Pregnant? Poster for vaccines against influenza and coronavirus

    Last update

    Pregnant women and infants have a higher risk of a severe disease course form coronavirus and influenza. Talk to your doctor about vaccines against influenza and coronavirus.
    Poster